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OVERTIDIG SVANGERSKAP 
Overtidig svangerskap er å betrakte som et risikosvangerskap. Studier har vist at det ved overtid er økt 
risiko for død i mors mage og i nyfødtperioden. I mange land settes derfor fødselen i gang en uke etter 
at terminen er passert, men i Skandinavia er det tradisjon for å la svangerskapet fortsette 2-3 uker etter 
at terminen er passert. Studier har vist at det å sette fødselen i gang også er forbundet med 
komplikasjoner for mor og barn. Behandlingen av det ellers ukompliserte overtidige svangerskap er 
kontroversiell.  
Avhandlingen består av 4 delstudier.  
I den første studien undersøkte vi hvordan det gikk med mor og barn i forhold til hvilken 
svangerskapsuke fødselen skjedde. Vi undersøkte også om det var forskjellige resultater for mor og 
barn om fødselen startet av seg selv eller ble igangsatt. Alle kvinner som fødte etter 37. 
svangerskapsuke ved St.Olavs Hospital i perioden 1990-2001 ble inkludert. Resultatene viste at 
komplikasjoner hos mor varierte med svangerskapslengden, og var lavest en uke før termin og høyest 
når svangerskapet var overtidig. Komplikasjoner for barnet varierte med svangerskapslengde bare hvis 
fødselen startet av seg selv. Igangsetting av fødsel var en risiko for komplikasjoner uavhengig av 
svangerskapslengde. 
Den andre studien sammenlignet sykelighet hos barna og komplikasjoner hos mor hvis fødselen ble satt 
i gang en uke over termin eller svangerskapet ble kontrollert hver 3. dag til hun var nesten 3 uker over 
terminen. Kvinnene trakk lodd om hvilken gruppe de skulle komme i, og til sammen deltok 508 
kvinner. Sykeligheten hos barna var den samme i begge grupper. Det var flere raske fødsler i gruppen 
som fikk fødselen igangsatt, men det var det ingen forskjell på forekomsten av komplikasjoner mellom 
gruppene. Keisersnittfrekvensen var lav. 
Kvinnene som deltok i den andre studien ble intervjuet om sitt syn på overtidig svangerskap når de ble 
inkludert. Dette ble gjentatt 6-8 måneder etter fødselen, og de ble da også spurt om hvilke erfaringer de 
hadde gjort seg og hvordan de ønsket å bli fulgt opp i et evt. fremtidig overtidig svangerskap. En uke 
over termin svarte 74% at de ønsket å få fødselen igangsatt. De fleste (84%) som fikk fødselen 
igangsatt rapporterte at dette var en positiv opplevelse, og 74% ønsket å bli igangsatt hvis de skulle bli 
overtidige i et fremtidig svangerskap. Bare 38% av de som kom i ventegruppen ønsket å vente. I 
gruppen som ble igangsatt var det flere raske fødsler, og kvinnene anga at riene var mer intense og 
hyppige i denne gruppen sammenlignet med ventegruppen. 
I den siste studien så vi på data fra Medisinsk Fødselsregister for alle fødsler etter 41 uker i Norge i 
perioden 1999-2005. Vi ønsket å studere forekomsten av fosterdød i mors mage og død i tidlig 
nyfødtperiode og regne ut hvor mange fødsler man måtte sette i gang for eventuelt å unngå 1 dødsfall. 
Forekomsten av dødsfall var lav, men økte med svangerskapslengden. Ved uke 41 må man sette i gang 
> 500 fødsler for å unngå 1 dødsfall, ved uke 43 < 200. Hvis vi i Norge skal sette alle fødsler i gang 
ved 41 uker, vil dette medføre > 14.000 igangsettinger i året. 
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IUFD  Intrauterine fetal death 
4 Introduction 
The most famous post-term delivery in the past was the delivery of Princess Charlotte 
Augusta of Wales in 1817. She was the only eligible heir to the British throne, and when her 
pregnancy was announced, the entire nation was closely following the most important event 
of that time. 
 At approximately 43 weeks her water broke and labour soon began spontaneously. 
Contractions were weak and the first stage of labour lasted more than 50 hours. Gradually, the 
fluid became meconium stained.  After 24 hours in the second stage of labour and after five 
hours of active pushing, she spontaneously delivered a stillborn boy. The baby appeared to 
have been dead for several hours. During the third stage, placenta was retained, and she had a 
post-partum haemorrhage from uterine atony. Princess Charlotte died approximately six hours 
after delivery. 
Three months later her obstetrician, Dr. Croft, committed suicide, unable to bear the 
burden of the responsibility for the death of the British heir to the throne. 1
As this event resulted in the death of an infant, the mother and her physician, it has 
historically been referred to as the "The Triple Obstetric Tragedy."  
 
Princess Charlotte Augusta of Wales    
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4.1 Definition 
 
Post-term pregnancy is defined by WHO and FIGO as a pregnancy with a gestational length 
of 294 days or more (i.e. 42 completed weeks or more).2, 3 In a survey to all birth units in 
Norway in 2003, only 6 of 43 units defined post-term pregnancy according to WHO, and  the 
majority of units (37/43) defined post-term pregnancy as 296 days or more.4 In some 
international studies, however, post-term is used for women at a gestational age of 41  
weeks.5-7
 Postmaturity (or postmaturity syndrome) is a clinical condition describing an infant 
born post-term with a poorly functioning placenta. The infant usually appears long and thin, 
with dry scaly skin and long finger nails, and in some cases there are meconium staining of 
the skin and membranes.  It has been suggested that postmaturity syndrome is really just fetal 
growth restriction in post-term fetuses.6  
 
4.2 Gestational length 
 
4.2.1 Estimation of day of delivery 
 
Hermann Boerhaave (1668-1738) was Professor of Botany and Medicine at the University of 
Leyden. He was the first to set down the calculation from which Naegele’s rule evolved. In 
the Academic lectures of Hermann Boerhaave “On conception” (published in 1744), the 
relevant passage translates as follows: “Women for the most part are impregnated after the 
end of their period: Numerous experiments undertaken in France confirm this: for of one 
hundred births altogether, ninety-nine came about in the ninth month after the last 
menstruation by counting one week after the last period and by reckoning the nine months of 
gestation from that time.”8
Franz Carl Naegele (1778-1851), Professor of Obstetrics at the University of 
Heidelberg, quoted this statement in his text from 1812 and also made his own observations 
on the ability and timing of conception in women. Naegele’s rule assumes a 28-day-cycle 
with ovulation on day fourteen. By adding seven to the first day of the last menstrual period 
and counting back three months the expected date of confinement is reached. This is the 
method by which Naegele’s rule has been calculated during this century. It is possible that 
Boerhaave and Naegele have been misinterpreted, and that their original rule may have been 
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to add seven days to the end rather than the beginning of the last menstrual period. This would 
achieve the same result as ultrasound with respect to induction of labour for post-term 
pregnancy.8
However, only 10-40% of women can recall the exact date of the first day of their last 
menstrual period (LMP), and the LMP estimated date of delivery (EDD) might be biased of 
amenorrhea, irregular menstrual cycles or use of oral contraceptives.9, 10 Due to the 
unreliability of this method, new technology and methods have been introduced to estimate 
date of delivery during the last decades. Ultrasound estimation of gestational age is based on 
the assumption that early fetal growth is uniform in all fetuses. Blaas et al. showed that first 
trimester embryos have parallel growth irrespective of their menstrual age, implying that 
embryos of the same size have approximately the same age.11 The first reliable method of 
predicting gestational age based on ultrasonic measurement of the biparietal diameter (BPD) 
was described in 1969 by Campbell.12 Several studies have indicated that ultrasonic 
measurements of BPD, crown-rump length (CRL) or femur length (FL) are better than the 
LMP to predict the day of delivery.13-16 There are several formulas and methods of estimating 
the date of delivery by ultrasound, and the best method is still a matter of discussion.17-19 
Ultrasound is also found to be a reliable method in pregnancies conceived with assisted 
reproductive techniques, and assessment of gestational age from the time of  IVF, CRL and 
BPD showed equally high agreement between the three methods.20 Today ultrasound is the 
method of choice for dating pregnancy, and the technology is available in most countries 
worldwide.21 In Norway this is an offer provided by the health care system and 97% of 
pregnant women attend the routine ultrasound screening around 18 weeks.10  
Several studies have demonstrated that LMP dates systematically overestimate 
gestational age compared with scan dates, suggesting that most pregnancies considered to be 
post-term according to LMP are in fact misdated.10, 22, 23 The most prominent difference in the 
distributions of births is the absence of the tail of post-term births for ultrasound dated 
pregnancies.10 In a study by Blondel et al., the proportion of births 42 weeks was 6.4% when 
the LMP method was used, but only 1.9% when ultrasound was used.24 Similar results were 
found in a Norwegian study by Tunon et al. (10% versus 4%, p<0.001).10 Routine ultrasound 
examination in early pregnancy results in reduced incidence of induction of labour for 
apparent post-term pregnancy.25, 26 In a study by Eik-Nes et al. there was a 70% reduction in 
the incidence of induced labour for apparent post-term pregnancies for women who were 
routinely screened with ultrasound compared to women who did not receive ultrasound 
routinely.27
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 In addition to LMP and ultrasound, gestational age can be determined by physical 
examination of the uterus, when the pregnancy test was first positive or a combination of 
several different methods. Some studies on post-term pregnancy have used several methods to 
estimate gestational age, which makes it difficult to interpret the results.28, 29 In the Canadian 
Multicenter Post-term pregnancy trial (CMPP) the following methods to determine gestational 
age was used: according to LMP if the woman had had regular cycles without use of oral 
contraceptives or the known date of conception, confirmed by a pregnancy test at < 6 weeks, a 
physical examination at  20 weeks or ultrasound at  26 weeks; by ultrasound at  26 weeks 
if LMP was uncertain; or by ultrasound on two occasions at  26 weeks that resulted in 
consistent estimates of gestational age, if LMP was unknown.30  
   
4.2.2 Duration of pregnancy 
 
For many centuries it has been accepted that the normal gestational period for humans is nine 
calendar months. The more exact duration of a pregnancy has been topic for research and 
discussion for years.8, 15, 31 WHO has defined the length of pregnancy to be 280 days, which is 
a slight modification of Naegele’s rule.2 However, several studies suggest that duration of 
pregnancy should be 281-283 days.10, 31 Deliveries are not normally distributed. Thus, mean 
values of duration of pregnancies must be inaccurate. The median value implies that 50% 
deliver before and 50% after that day, whereas the mode value represents the day most 
women deliver. In the study with data from the Swedish Birth Registry from 1976-1980, the 
mean duration of pregnancy was 281 days, mode 282 days and median 282. In a Danish study 
the median gestational age at delivery, estimated by ultrasound in the first and second 
trimesters and by corrected LMP according to cycle length, were 282, 280 and 283 days 
respectively.32 When dating methods are compared, elective deliveries may influence mean, 
mode and median values of pregnancy length. To avoid this problem some studies only 
include deliveries with spontaneous onset of labour. A “time to event” analysis with censoring 
elective deliveries at the time they occur can also be used. In a study by Smith, the median 
time to delivery from the Kaplan-Meier product estimate was 283 days.33 A new computer-
based estimation of “time to delivery” and estimation of date of delivery has been developed 
by Eik-Nes et al. (article in press, Ultrasound Obstet Gynecol). 
 Duration of pregnancy varies in different populations. One theory is that cervical 
ripening occurs in a timely, species specific manner in which programmed cell death 
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(apoptosis) may play a role. Apoptosis may be a genetically timed event and could explain the 
variation of pregnancy length, including the variation between different ethnic groups.34
 Likewise, duration of pregnancy may vary with the gender of the fetus, although 
results from different studies are inconsistent. Some have found no difference, whilst others 
have found that boys tend to be born earlier.31, 33  In comparison with dating by last menstrual 
period, the EDD in male-gender pregnancies has been found to be adjusted by ultrasound 
fetometry to be earlier, and in female-gender pregnancies to be later, with a mean difference 
of 1.50 days.35
 In a survey to all birth departments in Norway in 2003, all departments defined 282 
days as duration of pregnancy.4 In daily clinical practice “Snurra” has been widely used for 
estimating gestational age in Norway. “Snurra” is a practical facility prepared by Eik-Nes and 
Grøttum and is based on duration of pregnancy of 282 days.  
 
4.2.3 Discrepancy between LMP and EDD by scan 
 
The EDD estimated by ultrasound is usually later than the LMP date. Some studies report that 
fetuses who are smaller than expected at a second trimester ultrasound examination have a 
higher risk for bad outcome, but this is disputed by others.36-38 Tunon et al. compared groups 
where the EDD by scan differed more than 14 days or less than 7 days from the LMP 
estimate.37 They reported no statistically significant differences of perinatal morbidity and 
mortality. However, they did report a RR of perinatal death of 2.07 with a CI 0.93-4.61, and 
suggested further studies, as an extensive discrepancy in gestational age could be a marker for 
fetuses that might benefit from closer monitoring. Nakling and Backe found that a 
discrepancy between LMP and EDD by scan of more than 14 days was a risk factor for 
preterm delivery, birth-weight < 2500 g, SGA and perinatal death.38 It has been claimed that a 
large discrepancy between LMP and EDD by scan may indicate early disturbances in 
fetal/placental development and growth restriction. The risk in one study increased 
significantly with pregnancy length, and at least a part of the increased risk for poor 
pregnancy outcome in adjusted pregnancies was due to not recognizing true post-term 
pregnancies.39
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 4.3 Etiology 
 
The etiology of post-term pregnancy is not known. Since we do not know the mechanisms for 
initiating spontaneous labour, the reasons for post-term pregnancy will probably remain 
unsolved for years to come. Multi-factorial causes have been postulated since explanatory 
models are unproven. 
 
4.3.1 Risk factors for post-term pregnancy 
 
The duration of pregnancy tends to be shorter if the fetus is a boy,31 but a pregnancy with a 
male fetus is also a risk factor for post-term pregnancy.40 The uncorrected OR for having a 
male baby at ุ 42 weeks was 1.41 (95% CI 1.33–1.49) in one study. 41 After adjusting 
gestational age by ±0.75 days, the OR was reduced to 0.90 (95% CI 0.84-0.95). 35 The risk for 
labour induction was increased in male-fetus pregnancies delivered after 41 weeks when 
gestational age was corrected for fetal gender.41 
In a Swedish study, the risk of post-term pregnancy also increased if the woman was 
primiparous.42 It seems that maternal age is a risk factor. The incidence of deliveries beyond 
41 weeks is reported to increase as maternal age increase, but also among teenagers.42, 43 For 
multiparous women there is a tendency to deliver post-term more often after a long 
interpregnancy interval.44 However, the risk of recurrence of post-term delivery can be 
reduced when the first and second child have different fathers.45
Only a few studies address specific environmental, occupational or life-style 
exposures and post-term pregnancy. Occupational exposure to ethylene oxide has been 
reported to increase the risk of both preterm and post-term birth, and after the Chernobyl 
accident an increase in post-term births was reported in Ukraine and Belarus.46 Several studies 
have demonstrated a relation between fish intake and duration of pregnancy, and a Danish 
study reported that a fish free diet was associated with a reduced risk of post-term delivery.47 
Also smoking has been found to reduce the risk of post-term delivery, and this was most 
pronounced if gestational age was based on ultrasound.48 Post-term pregnancy has also been 
found to be associated with obesity (BMI > 30).49   
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 4.3.2 Genetics 
 
Duration of pregnancy varies with ethnicity. The average length of pregnancy is found to be 
about 5 days shorter in black populations than in white populations.50 This implicates that the 
post-term complications and postmaturity syndrome may occur at a shorter gestational age in 
black populations. 
 The recurrence risk of post-term delivery can be reduced when the first and second 
child have different fathers.45 This suggests that paternal genes may play a role for the 
gestational length. However, changing a partner is also likely to include changes in 
environmental factors and a longer interpregnancy interval, and this could be the explanation 
rather than the paternal genes. In a large Danish study the duration of the first pregnancy of 
both female and male twins were studied. The results suggested that 23-30% of post-term 
pregnancies were due to genetic factors, and that only maternal genes influenced pregnancy 
length.51  
Studies across generations are difficult because the methods of estimating EDD have 
changed over time, and the prevalence of post-term pregnancies may vary over generations 
due to environmental factors. Study results are somewhat conflicting. One study found that if a 
mother delivered post-term, the relative risk (RR) was moderately increased for her daughter 
to deliver post-term (RR 1.3, CI 1.0-1.7).52 Other studies concluded that variability in 
gestational age could not be determined by genetic factors.53 In a recent Norwegian study, 
both paternal and maternal gestational age at birth were found to be related to gestational age 
of their offspring. However, the association in gestational age was much stronger between 
mother and child than between father and child.54 Individual risk factors seem to be more 
important, as a previous post-term pregnancy increase the risk of a subsequent post-term 
pregnancy 2-3 times.52
 
4.3.3 Hormones 
 
Some congenital anomalies (anencephaly, trisomies 16 and 18) are associated with post-term 
delivery. This also applies to conditions that alter the fetal adrenal-pituitary axis (absence of 
the fetal pituitary or fetal adrenal hypoplasia).46 The explanation may be that these conditions 
lack the high concentrations of estrogen seen in normal pregnancies. Some studies have found 
that maternal levels of estradiol and estriol increase at the time of delivery,55 whereas others 
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found no difference.56 Some have proposed that the estrogen/progesterone-ratio is important 
for the start of labour, and that the changes in steroid hormone concentrations may occur 
locally within intrauterine tissues, since both fetal membranes and decidua can syntesize and 
metabolize estrogen and progesterone.55  
Progesterone is important for the maintenance of pregnancy, and in many species a 
progesterone withdrawal will cause delivery.57 However, there is no decline in plasma 
progesterone levels in humans at the time of parturition, and progesterone levels continue to 
increase in pregnant women up to the time of delivery. Nevertheless, a withdrawal of 
functioning progesterone may be linked to the initiation of the parturition even in humans. 
Human amnion and chorion have the capacity to convert progesterone to the inactive 20Į-
dihydroprogesterone.58 The metabolic inactivation of progesterone by fetal membranes 
increases with advancing pregnancy and the onset of parturition.57 This supports the 
hypothesis that progesterone withdrawal could be mediated by target tissue inactivation. 
Progesterone withdrawal could also occur through the action of endogenous anti-
progesterone. Some studies have demonstrated that anti-progesterone (mifepristone - RU486) 
can be used to induce labour and ripen the cervix.59 This is questioned by others.60 Thus, the 
role of progesterone in the endocrine regulation of human parturition is still unclear. 
It has been proposed that estrogen formed from fetal adrenal androgen is central in the 
initiation of parturition.61 When androstenedion infusion was given to pregnant monkeys, an 
increased level of estradiol and oxytocin were observed, and delivery occurred earlier 
compared with a control group.61 A study of the hormonal status in a group of women that 
underwent induction of labour found a higher level of DHEA-S in the group with favou able 
cervix than in the group with unfavourable cervix, while the level of estradiol, estriol, cortisol 
and progesterone were the same.56 A correlation between DHEA-S and cervical ripeness has 
later been demonstrated in other studies, and low levels of DHEA-S have been found to 
predict a need for oxytocin augmentation during labour and unsuccessful labour  
induction.62, 63
As far as we know, there are no studies on hormonal levels in post-term pregnancies. 
Post-term women may have different hormone status compared with women who deliver at 
term or preterm. Unpublished data from the Norwegian SGA-study, suggests that women with 
high levels of androgens during pregnancy tend to deliver earlier than women with low 
androgen levels, and in particular if the fetus is growth restricted (Carlsen-personal 
communication). 
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4.3.4 Start of labour  
 
A fundamental question in human physiology is still unclear: How is the timing of parturition 
regulated, and what triggers the cascade of events leading to delivery?  
In addition to hormones, there are numerous physiological, biochemical and 
biomechanical factors involved in parturition. The process probably involves the mother, 
fetus, placenta, membranes, cervix and myometrium.  
The association between a father’s gestational age at birth and his offspring’s 
gestational age at birth suggests that paternal genes are involved.54 This supports a hypothesis 
that the fetus is involved in the onset of labour. 
The process of cervical ripening is complex, and only fragments of the process will be 
discussed here. Anatomical and morphological changes are considerable, and a predominate 
change in cervical ripening is the rearrangement of collagen.34 Connective tissue containing 
collagen and elastin has a characteristic property to reorganize its structure in response to a 
mechanical stretch or force. During the first stage of labour, mechanical stretching of the 
cervix occurs with the force of uterine contractions. The mechanical manipulation causes 
increased levels of prostaglandin F2Į which in turn will increase uterine contractions – a 
physiological response called the Ferguson’s reflex.34 The mechanical pressure exerted on the 
cervix of the presenting part of the fetus, cause both realignment of the collagen and 
stretching of the elastic fibres.34 Collagenases and other matrix metalloproteinases contribute 
to the reorganization of collagen and cervical ripening. It has been proposed that DHEA-S 
causes collagenase activation and thereby remodelling of uterine connective tissue.62 The 
changes in the extracellular matrix, including a 30 % reduction of the collagen concentration, 
a 50% decrease in the small proteoglycan decorin and a 15% increase in the large 
proteoglycan versican contribute to the softening of the cervical tissue.64 Versican has the 
capacity to attract water and bind hyaluronan, resulting in disintegration of the collagen 
bundles and a change in the physical properties. This will produce a soft and elastic tissue and 
facilitate dilation of the cervix. Decorin, the major proteoglycan in the human cervix, 
influences collagen fibrillation and rearrangement, and thus, the stiffness of the cervix.65 
Several studies have demonstrated the involvement of different types of matrix 
metalloproteinases in the cervical ripening process. MMP–1, MMP-3 and MMP-8 were found 
to be involved in one study,64 and MMP-2 and MMP-9 in another study.66  
It has also been proposed that cervical ripening can be regarded as an inflammatory 
reaction. The levels of mRNA encoding IL-6, IL-8 and granulocyte colony-stimulation factor 
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are increased 100-fold during cervical ripening, and prostaglandin degradation occurs.65 
Prostaglandins are involved in the onset of human parturition, and in particular the E and F 
series have well-established roles in labour. PGE2 is a potent uterotonic agent produced 
within the amniotic cavity in increased amounts before and during labour and it plays a 
central role in the cervical ripening process. This will be discussed later in the section about 
induction of labour. A newly published study suggests that also D-synthase might play 
important physiological roles in the placenta and potentially having a regulatory role in the 
processes of parturition.67 There are, however, several unknown factors, and the knowledge of 
the complicated physiological process of parturition is still limited. 
 
4.4 Prevalence of post-term pregnancies 
 
The reported prevalence of post-term pregnancies vary between 5.5% and 9.5% in different 
studies, countries and time periods.68, 69 In Scandinavia, the prevalence has been stable around 
7-8% during the last years.27, 28  
 Some studies report decreasing prevalence rates, possibly due to more reliable dating 
methods or a change in obstetric management towards a more aggressive induction policy. In 
Spain the prevalence decreased from 8.1% in 1980 to 5% in 1992.70 The same trend was seen 
in Australia, where prevalence of deliveries at or beyond 42 weeks was 4.6% in 1990, and 
2.8% in 1996.71 In an Australian study a general shift towards births at earlier gestational ages 
was reported.71 This contrasts the situation in Norway, where the proportions of deliveries at 
different gestational ages have been relatively stable over the last decades. However, the 
proportion of deliveries beyond 42 weeks has decreased even in Norway, especially after 
1992. (Table 1) 
 
Table 1. Proportions of deliveries (%) beyond term in Norway 1968-2002 according to 
statistics from the Medical Birth Registry of Norway. 
 
 1968 1972 1976 1980 1984 1988 1992 1996 2000 2002 
40 27,2 26,9 27,3 27,3 26,9 26,3 25,6 26,3 24 23 
41 20 20,8 21,3 21,4 21 20,3 20,1 20,7 18 18 
42 9,2 10,4 10,6 10,4 10 9,5 9,6 10,1 9 8,7 
+43 5,1 5,9 5,2 4,4 4,6 4,6 4,9 2,7 2,8 2,7 
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4.5 Complications of post-term pregnancy 
 
The incidence and severity of complications vary from study to study, usually reported as the 
number of complications per 1000 deliveries.28, 29, 72 However, as pointed out by Yudkin et 
al., fetuses at risk of stillbirth at a specific gestational age must include all live fetuses at risk 
at that particular gestational age.73 He argues that the number of stillbirths per ongoing 
pregnancies is the appropriate risk estimate to be used. Thus, stillbirths and early neonatal 
deaths should be reported separately and appropriate denominators must be used.74 The most 
frequently cited study on post-term pregnancy and stillbirth risk is a study by Hilder et al.75 
The stillbirth rate per 1000 ongoing pregnancies was found to increase from 0.35 at 
gestational week 37 to 2.12 at week 43, whereas the stillbirth rate per 1000 births decreased 
from 6.2 to 1.5 from gestational week 37 -43.75  
Several studies using modifications of Yudkin’s model have been performed.76-79 An 
example of how Yudkin’s model can alter conclusions within a dataset was seen in a Swedish 
study. The authors reported an increased risk of stillbirths in post-term pregnancies for 
primiparous, but not for multiparous women when the denominator was per 1000 deliveries. 28    
By using the model of Yudkin on the same dataset (per ongoing pregnancies), increased risks 
were found in both groups.80, 81  
Yudkin’s model is useful to assess the short term risk of stillbirth.82 The short term 
risk of stillbirth is interesting for obstetricians in their daily clinical risk assessment and 
counselling of post-term women. The original Yudkin model risk estimated a two-week 
period and a revised model used a one-week period. A more useful clinical approach would 
be to give risk estimates for a few days only. The information a pregnant woman would like 
to know is the risk for stillbirth at her particular gestational age and the increased risk if the 
pregnancy is allowed to continue for a few more days.  
 
4.5.1 Perinatal and neonatal mortality 
 
Stillbirth and neonatal death are of course worst case scenarios, and post-term pregnancy 
increases the risk of both events.22, 28, 75, 83 Several studies have reported increased stillbirth 
rate from 41 weeks gestation,42, 75, 84 and some have reported increased risk from 40 weeks 
gestation.77 In a study from the National Swedish Medical Birth Registry, the odds ratio for 
fetal death was 1.5, 1.8 and 2.9 at 41, 42 an 43 weeks respectively compared to 40 weeks.42  
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Some studies report a summarized risk of  stillbirth and neonatal death, which was 
slightly increased in post-term pregnancies compared to term pregnancies (OR 1.36; 95% CI 
1.08-1.72).85 Other studies have divergent conclusions, and some found that neonatal 
mortality was independent of gestational age.29, 42  
It has been suggested that the increased mortality rate in post-term pregnancies is due 
to fetal growth restriction. One study found that fetal growth restriction was associated with 
significantly higher odds ratios for both fetal and neonatal mortality rates for every gestational 
age between 40 and 43 weeks, with odds ratios ranging from 7.1 to 10.0 for fetal death and 
3.4 to 9.4 for neonatal death.42 In a large Swedish study of more than 500.000 deliveries, the 
increased risk of stillbirth in post-term pregnancies was found to be associated with an 
increased rate of small for gestational age infants (SGA)(OR 10.56; 95% CI 6.95-16.05).72 
When SGA-births with congenital malformations were excluded, the risk of infant death 
decreased considerably.72 In this study there was no significant increase in stillbirths or infant 
deaths among appropriate for gestational age infants born post-term compared to those born at 
term. In a study of variables associated with perinatal mortality in post-term infants in a ten 
year cohort of Norwegian births, SGA births had a risk of perinatal death almost six times 
greater than non-SGA births (adjusted RR 5.68; 95% CI 4.37-7.38).6 The second most 
influential risk factor was maternal age 35 years or older (adjusted RR 1.88; 95% CT 1.22-
2.89). 6
 
4.5.2 Neonatal morbidity 
  
Since the risk of fetal and infant mortality is low, a possible association between morbidity 
and post-term pregnancy is more of concern in daily clinical work. A number of neonatal 
complications have been associated with post-term pregnancy, e.g. meconium aspiration, 
NICU admission, fetal distress and convulsions. 
Several studies have reported an increased risk of meconium aspiration, which in turn 
is associated with neonatal morbidity.72, 85-87 NICU admission rate is increased for post-term 
neonates.29, 88 Fetal distress has also been associated with post-term pregnancy.85, 89, 90 The 
diagnosis of fetal distress is usually based on low Apgar scores or fetal acidemia. The risk of 
low Apgar score at five minutes has been found to be increased in post-term compared to term 
deliveries in some,72, 87, 91 but not all studies.29 Umbilical artery pH <7.0 was associated with 
post-term pregnancy in one study,92 while others were unable to confirm this.29 In a study of 
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Caughey et al. the adjusted OR for pH < 7.0 was 1.65 at 41 weeks and 2.31 at 42 weeks when 
gestational week 39 was used as reference.92 Further, they found that umbilical cord pH 
decreased with increasing gestational age. This is in accordance with the results in a study by 
Kitlinski et al.92, 93  Kitlinski et al. proposed that gestational age adjusted cut-off  levels of pH 
should be used to avoid a diagnosis of acidosis when umbilical artery pH are within the 
normal limits of a particular gestational age. 
A study by Caughey et al. did not have sufficient power to demonstrate statistically 
significant differences when each complication was studied separately according to 
gestational age. However, the summarized complication risk increased from 40 weeks 
gestation.92 Other complications found to be associated with post-term deliveries are 
convulsions, birth trauma (skull fracture, plexus brachialis injuries), intracranial haemorrhage, 
neonatal sepsis and respiratory distress syndrome.85 Olesen et al. found increased OR for 
these complications in post-term births (1.22-1.90) compared with term births.85
 Most neonatal morbidity measurement instruments are developed for preterm 
neonates. In most studies on post-term deliveries, neonatal morbidity was not properly 
defined. In general, the measurements used were expressions of morbidity, such as low Apgar 
score and NICU transfer. The largest reported randomised trial on post-term pregnancy is the 
Canadian Multicenter Post-term Pregnancy Trial (CMPP).30 The trial used a novel neonatal 
morbidity index. The morbidity index was defined after the first 1500 infants had been born, 
and a consensus conference was held to define measures of neonatal morbidity. Outcome 
measures for neonatal morbidity used in a recent Cochrane review were: Birth asphyxia (as 
defined by trialists), admission to NICU, neonatal convulsions, neonatal encephalopathy, use 
of anticonvulsants, meconium aspiration syndrome, pneumonia, Apgar score less than seven 
at five minutes and neurodevelopment at childhood follow-up. 
 
4.5.3 Long term outcome for children 
 
There are very few studies on follow-up of children born post-term. In a study from Toronto, 
184 normal term controls and 129 infants born beyond 294 days were followed for 1-2 years 
to examine the influence of prolonged pregnancy on infant development.94 The conclusions 
were that infant development were similar for term and post-term infants.95  
 In a study by Field et al. post-term infants had a greater head circumference at one 
year of age compared with controls.96 This was also observed in a Swedish study, in which 
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the head circumference was more than 2 SD above the mean for children born at term (14.2% 
versus 8.8%, p=0.031).97 However, a large head circumference did not correlate to poor 
developmental outcome.97 A multiple logistic regression analysis indicated, however, that the 
children born post-term had higher risk for developmental deviations than children born at 
term (13.1% versus 5.5%, OR 2.20; 95% CI 1.29–3.85). The analysis also demonstrated that 
males generally had more neurodevelopmental disorders than females (OR 1.92; 95% CI 
1.11–3.45).97 Instrumental delivery, SGA and traumatic birth injury did not influence on the 
odds ratio for developmental deviation.97  
 
4.5.4 Maternal outcome 
 
Several studies have reported increased risk of caesarean section and operative vaginal 
deliveries in post-term deliveries.88, 98 Operative deliveries and maternal complications are 
therefore matters of concern in studies of post-term pregnancy management.22, 30, 89 In a case-
control study of Luckas et al., there was an increased risk of caesarean section due to fetal 
distress (RR 2.0; 95% CI 11.14-3.61) and failure to progress in labour (RR 1.74; 95% CI 
1.02-3.04) in post-term deliveries.88 Long duration of labour and prolonged second stage have 
also been associated to post-term labours,29 as well as post-partum haemorrhage.85, 98 Olesen 
et al. found an overall maternal complication frequency of 30%, including operative 
deliveries, post- partum haemorrhage, cervical lacerations, dystocia and puerperal infection.85 
In general, maternal complications are associated with large fetal size, and fetal complications 
are associated with small fetal size.6
 
4.6 Management protocols 
 
No management protocol for post-term pregnancy is considered to be the gold standard, and 
management protocols may vary from country to country and from hospital to hospital. There 
are different suggestions to the questions when follow-up examinations should start, what 
kind of examinations the follow-up should include, and how frequently the follow-up 
examinations should be done. Proposed guidelines will be discussed in detail later. 
 Up to date, there are no examinations with convincing positive or negative predictive 
values for bad outcome. In an English study, it was concluded that when extensive post-term 
pregnancy follow-up was done, more interventions were performed without any improvement 
of pregnancy outcome.99  
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 Studies on efficacy of  post-term antenatal surveillance from 41 weeks onwards 
compared with 42 weeks onwards need to consider pregnancy outcomes, logistic issues and 
cost-benefit analyses. In a study of Bochner et al. the total number of adverse outcomes in a 
group of women who started antenatal surveillance at 42 weeks was found to be significantly 
increased compared with a group starting surveillance at 41 weeks.100 The authors proposed, 
however, that a randomised controlled trial was needed to determine the optimal time to start 
post-term surveillance, and to address the additional manpower, expenses and necessary 
facilities needed.100   
 
4.6.1 CTG 
 
Cardiotocography (CTG) records fetal heart rate, fetal movements and uterine contractions to 
assess signs of fetal hypoxia. No other examination in obstetrics is more frequently used, but 
evidence based medical benefits are still lacking.101, 102 A Cochrane review concluded that 
there is not enough evidence to evaluate the use of antenatal CTG for fetal assessment.102 The 
trials included in the review are old, and the results may be difficult to relate to current 
practice.102 Still, CTG is performed as a part of post-term follow-up worldwide.103, 104 In a 
survey to all birth units in Norway in 2003, CTG was reported to be a part of the post-term 
follow-up in all units.4  
 There are no typical FHR patterns in post-term pregnancies. In a case-control study, 
2.2% was found to have FHR  160 and 5.5% had FHR  120 in the post-term group, but 
there were no differences in outcome between the term and post-term groups.105 
Computerized analysis of the fetal heart rate has found the variation to decrease with 
increasing gestational age, and reduced variability is a predictor of intrapartum fetal distress 
and acidosis in post-term deliveries.7, 106 Others have found an association between FHR 
abnormalities and amniotic fluid index (AFI).107, 108 Divon et al. found an AFI  5 cm to be a 
risk factor of FHR decelerations and meconium stained liquor.108 Further, the frequency of 
oligohydramnios and abnormal non-stress tests were inversely related to birth weight in the 
expectantly managed prolonged pregnancy.109 Maternal ketonuria in post-term pregnancy has 
been found to be associated with an increased incidence of non-reactive CTG, and a 
significant increase in FHR decelerations.110  
During labour, variable decelerations have been observed in up to two-thirds of post-
term deliveries, but it has been difficult to differentiate between fetuses in distress and those 
who experience a normal labour on the basis of variable decelerations alone.111
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 4.6.2 Amniotic fluid 
 
Post-term pregnancy is associated with oligohydramnios. The pathophysiologic mechanism 
responsible for the development of oligohydramnios has not been established. Estimation of 
the amount of amniotic fluid is recommended to be a part of post-term pregnancy 
management protocols.112 In Norway estimation of the amount of amniotic fluid is part of the 
post-term follow up in 95% of the birth units.4  
The amniotic fluid index (AFI) and measurement of the depth of the deepest pocket 
are both semi-quantitative measures of the amount of amniotic fluid. The AFI is a summary of 
the largest vertical pocket in each quadrant of the uterus. The pocket should not include an 
aggregate of cord or fetal extremities. There are divergent views on how the measurements 
should be performed and what criteria should be used.113  
AFI and the deepest pocket are usually reported in cm. AFI  5 cm or deepest pocket 
 2 cm is commonly considered indicative for oligohydramnios. Another option to estimate 
the amount of amniotic fluid is to make a subjective estimate, which is found to be correct in 
up to 70% of the cases.114
 Oligohydramnios is associated with fetal heart rate abnormalities and meconium 
stained liquor.107, 108 In a study by Alfirevic, five hundred women with singleton, 
uncomplicated pregnancies with gestational age  290 days were randomly allocated to fetal 
monitoring by either AFI and CTG or maximum pool depth and CTG. The proportion of 
abnormal AFI measurements was significantly higher than the proportion of abnormal 
maximum pool depths (10% vs 2.4%; OR 4.51; 95% CI 1.82-11.21). This resulted in more 
inductions for abnormal post-term monitoring in the AFI group, but there were no other 
statistically significant differences in perinatal or labour outcomes.115 This is in accordance 
with another RCT, where the conclusion was that the AFI offered no advantage in detecting 
adverse outcomes compared with the single deepest pocket.116 However, some propose that 
AFI is markedly superior as a predictor of fetal asphyxia before labour.117 In a UK study, AFI 
< 5 cm was significantly associated with caesarean section for fetal distress in labour, 
meconium aspiration, a cord arterial pH <7 at delivery and low Apgar scores.118 However, 
both AFI and single deepest pocket are poor diagnostic tests in identifying patients who will 
undergo caesarean delivery for non-reassuring FHR tracing or deliver a newborn with 
depression or acidosis.119  
 26 
Maternal hydration for increasing amniotic fluid volume have been suggested to be 
beneficial in the management of oligohydramnios.120 This is probably not a good strategy in 
post-term pregnancies, as induction of labour would be a more appropriate management plan. 
In a study of deliveries beyond 41 weeks gestation, AFI > 6 was found to be 
associated to longer duration of labour and a spontaneous labour was less likely to occur. 121
 
4.6.3 Fetal growth 
 
In the past, fetal growth was believed to stop at around 40 weeks with an equalization of the 
growth curves beyond term.122 Later studies have demonstrated that fetal growth continues in 
a steady and linear way until 42 weeks.123
 Data from the Norwegian Medical Birth Registry indicate that there has been a linear 
increase in birth weight per year for children born at 40 weeks gestation. The birth weight 
increase is estimated to be 4 g per year for all births, which corresponds to around 100 g over 
a 30 year period.123 In Denmark, the overall mean birth weight increased 45 g, and for infants 
born at term the increase was 61 g over a ten year period.124 The risk of having a baby 
weighing more than 4000 g increased from 17% to 20% in the same period.124 The proportion 
of children weighing more than 4500 g at birth was 3.2% in Norway in 1980 and  4.8% in 
1999.125  
 Macrosomia is associated with post-term preg ancies. Maternal anxiety and concern are 
often related to “the big baby” post-term.69 Still, induction of labour for suspected fetal 
macrosomia in non-diabetic women does not reduce the risk of maternal or neonatal 
morbidity.126, 127 However, one study found increased risk of stillbirth post-term if maternal 
age was > 40 years and fetal birth weight was moderately increased (2.5-9.9 percentile).128
 Small fetuses have a high risk for poor obstetric outcome in post-term pregnancies.6 
The incidence of SGA is increased in post-term births compared with term births (3.8% 
versus 2.2%).72 Fetal growth restriction has been associated with significantly higher OR for 
both fetal and neonatal mortality rates at 41-43 weeks. In a study by Divon et al. odds ratios 
ranged from 7.1 to 10.0 for fetal death and 3.4 to 9.4 for neonatal death.42 Thus, it is of 
outmost importance to diagnose fetuses at risk. Ultrasound can diagnose both macrosomia 
and growth restriction.129 In one study, ROC-curves (receiver operating characteristic curves) 
predicted birth weights <10th percentile (3125 g) and <5th percentile (2930 g) in 89% and 
96% of cases.130
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 In a Swedish study, a population based standard (adjusted for gestational age and 
gender) was compared to a customised birth-weight standard (based on the prediction of 
optimal growth in each individual pregnancy).131 The customized method was somewhat 
better to identify fetal growth restriction having an increased risk of adverse perinatal 
outcome.131  
 Eighty percent of Norwegian birth units estimate fetal weight by ultrasonography as 
part of their post-term follow-up.4  
4.6.4 Doppler ultrasound 
 
Doppler ultrasound has no proven benefit in monitoring the post-term fetus and is not 
recommended as part of post-term management protocols.132 One Doppler study has indicated 
that left and right fetal cardiac function was impaired in prolonged pregnancies, and this 
occurred before the appearance of an abnormal intrapartum FHR.133 However, in a Swedish 
study of very prolonged pregnancies (> 43 weeks), there was no association of fetal distress in 
labour and increased placental vascular resistance.134 Post-term pregnancies with 
oligohydramnios did not seem to differ in placental and fetal blood flow distributions from 
those with a normal amount of amniotic fluid.135
4.6.5 Cervix 
 
Information about cervical ripeness is important when induction of labour is considered, and 
evaluation of the cervix is therefore part of most management protocols. The traditional 
clinical method for evaluating the cervix is digital palpation and the use of “Bishop score”. 
Recently transvaginal ultrasound has become increasingly popular to measure the cervical 
length.  
4.6.5.1 Bishop score 
 
It is more than 40 years since Edward H. Bishop argued that a standardized evaluation of 
the cervix was required to determine suitability for elective induction.136 Five factors are included 
in the Bishop score: Cervical dilatation, effacement, consistency, position and the station of 
the presenting part. Each factor is scored on a scale from 0-2, and a Bishop score will range 
from 0-10. Bishop score > 6 is regarded as a favourable cervix, and  5 is regarded as 
unfavourable. 
The Bishop score is used worldwide and numerous studies on cervical assessment 
have been performed. Cervix is rarely found to be favourable in post-term pregnancies. In one 
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study only 8% was found to have a Bishop score > 6 at  42 weeks.137 In a Swedish study of 
103 women who were followed from gestational day 294 onwards, 73% of primiparous and 
53% of multiparous women had Bishop scores 0-5 at study entry.87 In this study, primiparous 
women experienced a more gradual ripening of cervix with increasing gestational length, 
whereas multiparous women often had a sudden change from unripe to ripe cervix. 
 The length of the induction to delivery interval is associated with Bishop score, and 
the likelihood of vaginal delivery within 24 hours has been found to increase with the Bishop 
score.138 Further analyses of the different components of the Bishop score demonstrated that 
only cervical length provided a significant contribution to the prediction of the likelihood of 
vaginal delivery within 24 hours.138 In another study, cervical dilatation was found to be more 
predictive of caesarean delivery than cervical effacement or presenting part station.139 This 
contrasts the study of Shin et al., where the fetal station was found to be more predictive for 
vaginal delivery than dilatation.140 Others have found dilatation, effacement and station to be 
better predictive factors to spontaneous onset of labour than consistency and position.137
 As the Bishop score is a subjective method, the numerical score may vary depending 
on the examiner. One study demonstrated that if a difference of one point between the 
observers was found acceptable, the inter-observer agreement was 66%. A formal Bishop 
score did not improve agreement as compared to an informal global evaluation.141 By 
replacing digital assessment of the cervical length by ultrasound measurements, the modified 
Bishop score was better than the original one in predicting the induction to delivery interval 
and the success of induction of labour.142
Several studies have assessed Bishop score and measurements by transvaginal 
ultrasound. Some studies find that the methods are comparable,143-145 some find Bishop score 
to be best,146 and others find transvaginal ultrasound to be the best method.147 Different cut-
off values have been used in different studies. In a study of Rozenberg et al., the prediction of 
labour within 7 days and normal vaginal delivery were similar with a Bishop score 6 or more 
and an ultrasound measured cervical length of 26 mm or less.143 In a study by Chandra et al., 
transvaginal ultrasound did not predict successful labour induction in post-term pregnancy as 
well as the digital examination did.146 However, patient discomfort assessed by visual 
analogue scales demonstrated significantly less discomfort with sonographic assessment of 
the cervix compared with digital examination.146 
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4.6.5.2 Transvaginal ultrasound 
 
In a Swedish study of 419 nulliparous and 360 parous women cervical length decreased with 
increasing gestational age beyond 32 weeks in both nulliparous and parous women, but the 
median cervical length tended to be longer in parous women from 33 to 41 weeks.148 In a 
study of Chinese women the mean length of the cervix was shorter throughout pregnancy 
compared with studies of Caucasians.149 This may be due to racial differences.  
In a UK study, cervical length was measured by transvaginal ultrasound at 37 weeks 
in 1571 singleton low-risk pregnancies.150 The median cervical length was 30 mm, and there 
was a significant association between cervical length and gestational age at delivery.150 The 
incidence of delivery after 41+3 weeks increased with increasing cervical length at 37 weeks 
(0%, 6%, 35% and 68% for cervical lengths of < 20, 21-30, 31-40 and 41-50 mm).150  
Transvaginal ultrasound measurements of the cervix may be more objective and 
accurate than Bishop score, because half the cervix is not palpable at digital vaginal 
examination when the cervical canal is closed. In one study sonographically measured 
cervical length was found to predict the outcome of induction better than the Bishop score or 
cervical length by vaginal examination.147 ROC curves (receiver–operating characteristics) 
demonstrated that ultrasound was better than Bishop score in the prediction of all caesarean 
sections (72% versus 68%) and caesarean sections for failure to progress (76% versus 
69%).151 This is in accordance with a study by Gabriel et al., which concluded that for women 
with unfavo rable Bishop score, a cervical length of < 26 mm was associated with a lower risk 
of caesarean section and a shorter duration of labour.152   
It is important to be able to predict failure of induction of labour. One study indicated 
that transvaginal ultrasound of the cervix was better than the Bishop score to predict a 
successful labour induction.153  If the cervix measured 32 mm or more, 85% of women 
remained undelivered after 24 hours compared to 65% undelivered if the Bishop score was 
two or less.153 However, study results are contradictory. Another study concluded that 
ultrasound did not improve the prediction of cervical inducibility obtained by the Bishop 
score.154 In nulliparous post-term women the use of a logistic regression model including both 
Bishop score and sonographic cervical length was more likely to predict the onset of labour 
within 24 hours than the use of Bishop score alone or ultrasound alone.155 In a Norwegian 
study, the mean distance from the outer bony part of the fetal skull to the skin of the perineum 
(fetal head–perineal distance) was measured by transvaginal ultrasound in women with 
prelabour rupture of membranes at term. Women with a short fetal head–perineal distance (< 
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45 mm) had statistically significant shorter time from rupture of membranes to start of labour, 
and a shorter time from induction to delivery.156
Recent studies have suggested that 3D ultrasound examinations of the cervix allow a 
more complete assessment of the cervix than the 2-dimensional (2D) ultrasound approach. 
However, the results of 3D power Doppler ultrasound examinations before induction did not 
predict outcomes of labour induction in post-term women.157 In prolonged pregnancy, cervical 
vascularisation (estimated by 3-dimensional power Doppler ultrasound) was related to time to 
delivery >48 hours. However, the likelihood of delivery >48 hours can be predicted equally 
well using Bishop score alone or sonographic cervical length alone.158
 
4.6.5.3 Fibronectin 
 
Measurements of fetal fibronectin in vagina or cervix have been introduced as screening 
methods to predict preterm labour. A high fetal fibronectin level is associated with delivery 
within the near future.159, 160 However, the use of fibronectin test has never been a well-
established part of post-term follow-up.161
In a retrospective study, fibronectin was measured in gestational week 39-40, and the 
presence of vaginal fibronectin concentration <60 ng/ml iden ified 96% of women who 
delivered beyond 41 weeks.162 For those who delivered before 41 weeks, a 35 fold increase in 
fibronection concentration was found.162 This contrasts the results of a Swedish study in 
which the concentration of fetal fibronectin in vaginal fluid was elevated in only 36 of the 80 
post-term women, and a positive fibronectin concentration had no correlation with delivery in 
two or three days.163 Mouw et al. have also concluded that fibronectin test can not predict 
whether birth will take place within three days or not.164
 
4.6.5.4 Insulin-like growth factor binding protein-1 (IGFBP-1) 
 
The detection of amniotic fluid isoforms of IGFBP-1 in cervical and vaginal samples is 
diagnostic for the rupture of fetal membranes.165 Phosphorylated isoforms of IGFBP-1, 
different from those found in amniotic fluid, are present in the cervical secretion of women 
with intact fetal membranes and reflect cervical ripeness.165 Nuutila et al. have suggested that 
a bedside test for phosphorylated IGFBP-1 isoforms might help to predict suitability for 
labour induction.165 Studies on IGFBP-1 and cervical ripeness in post-term pregnancies are 
lacking. 
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 4.7 Induction of labour 
 
Induction of labour has been associated with labour complications and in particular with 
increased risk of caesarean section.166, 167 Labour induction was associated with an increased 
caesarean delivery rate from 13.7% to 24.7% (OR 1.70; 95% CI 1.48-1.95) in primiparous 
women, and from 2.4% to 4.5% (OR 1.49; 95% CI 1.10-2.00) in parous women.168
Post-term pregnancy is a common clinical indication for labour induction. In the 
United States induction of labour is one of the most frequently performed medical procedures, 
and the proportions of induced labours increased from 9% in 1989 to 19% in 1998.169 The 
gestational age distribution curve for induced births has showed a marked shift to the left, and 
the proportion of all induced births occurring post-term fell from19% to 9% during the same 
time period, whereas term induction increased from 73% to 83%.169 This change has not been 
observed in Norway. The proportion of induced labours in Norway has increased over the last 
years, but the proportion of induced labours are still relatively low (12% in 2002, according to 
data from the Norwegian Medical Birth Registry). The proportions of induced labours post-
term are in accordance with the results from the survey to Norwegian birth units (Table 2). 
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Table 2. Induced labours beyond 41 weeks gestation in 2003 according to statistics from the 
Norwegian Medical Birth Registry. 
 
Gestational 
age, days 
Number of 
births 
Number of 
induced  labours 
Proportion of 
induced labours, 
% 
287 1 843 157 9
288 1 712 162 10
289 1 612 165 10
290 1 448 168 12
291 1 322 175 13
292 1 191 178 15
293 993 176 18
294 931 166 18
295 805 220 27
296 811 357 44
297 730 404 55
298 426 249 59
299 257 168 65
300 119 73 61
 
4.7.1 Methods 
 
There are numerous different methods for induction of labour, which is reflected in 24 
different Cochrane reviews on the topic. In a survey to all birth units in Norway in 2003, 
about 50% of the units used dinoprostone gel for induction of labour and 25% used 
misoprostol.4 There were a total of 24 different administration and dosage regimens in use.4 
Only a few methods will be discussed here, primarily the methods recommended in the 
Norwegian Guidelines for Obstetrics.170  
A number of “old wives” tales are still used by many women to encourage start of 
labour. Among the more common approaches are frequent walking, vaginal intercourse, 
participating in heavy exercise, consumption of laxatives, spicy foods or herbal tea, nipple 
stimulation and administration of an enema.171 There has been some research on these 
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methods, and even a few Cochrane reviews exist, but the research is inconclusive, and there is 
usually no evidence of effect.172-175  
Studies usually compare efficacy of labour induction methods stratified into whether 
cervix is favourable or unfavourable, although cervical ripening is a continuum. When cervix 
is unfavourable, prostaglandins are usually the preferred method for cervical ripening. 
Prostaglandins have been used for induction of labour since the 1960s, and many studies have 
been reported since then. From the early 1990s, the synt etic prostaglandin analogue 
misoprostol has been used and appears to be at least as effective as more conventional 
prostaglandins.176, 177  
The results on effect and side-effects of prostaglandins are conflicting. Both 
prostaglandin E2 and F2a are found to increase successful vaginal delivery rates within 24 
hours without increasing operative delivery rates.178 However, uterine hyperstimulation with 
or without FHR changes have been associated to the use of prostaglandins and related to the 
dosage.177, 178 The definition of uterine hyperstimulation varies. In one study hyperstimulation 
was defined as tachysystole (> 5 contractions per 10 minutes for at least 20 minutes) or 
hypersystole (contractions lasting at least 2 minutes),177 while others defined hyperstimulation 
as tachysystole with fetal heart rate changes.179 A systematic review of studies on misoprostol 
compared with prostaglandin E2 for labour induction at term, (with intact membranes and 
unfavourable cervix) demonstrated no difference in the risk of caesarean delivery. However, 
the use of misoprostol was associated with a higher risk of tachysystole (RR 1.86; 95% CI 
1.01-3.43) and hyperstimulation (RR 3.71; 95% CI 2.00-6.88).179 The optimal method of 
induction of labour, including route of administration and dosage, is still under debate.  
  When cervix is favourable, the recommended methods are sweeping of the 
membranes, amniotomy and/or oxytocin. Amniotomy and membrane sweep are frequently 
requested by women wanting a drug-free labour. The available evidence suggest that 
membrane sweep promote the onset of labour.180 In one study, membrane sweeps increased 
the spontaneous vaginal delivery rate, shortened induction to delivery interval, and improved 
patient satisfaction.181 In a RCT of low-risk pregnancies at 41 weeks, serial sweeping of the 
membranes decreased the risk of post-term pregnancy (RR 0.57; 95% CI 0.46-0.71, NNT 
6).182  
 Oxytocin is the most frequently used induction agent worldwide. It may be used alone, 
in combination with amniotomy or following cervical ripening with other pharmacological or 
non-pharmacological methods.183 A Cochrane-review included 40 trials and 5893 women, and 
found that using PGE2 rather than oxytocin was probably more effective to induce labour.183 It 
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is noteworthy that there was no increase in uterine hyperstimulation with fetal heart rate 
changes in any of the comparisons. This contrasts the common belief that the use of oxytocin 
is associated with fetal distress and adverse outcome.183, 184 The combination of amniotomy 
and intravenous oxytocin have been widely used in obstetric practice, but surprisingly little 
research have been done. Meta-analyses do not clearly support or refute the value of using a 
combination rather than separate methods individually, and no recommendations for clinical 
practice have been made.185 A review of trials in the Cochrane database did not find evidence 
to support the use of amniotomy alone for induction of labour.186
 
4.7.2 Economical considerations 
 
Cost is a major issue when recommendations about induction of labour are considered. 
Obviously the costs of induction include far more than the price of the medications used. 
Induced labours are “high risk labours”, and additional monitoring is required. According to a 
Canadian study, the costs of delivery after induction of labour was increased compared to 
spontaneous onset of labours ($1715 versus $1474, P<0.001).187 In a theoretical study, 
induction of labour at gestational age 40, 41 and 42 required expenditures from the medical 
system regardless of parity and cervical ripeness, and induction of labour was never cost 
saving.188 However, for parous women and for women with a favourable cervix, inductions 
were less expensive at later gestational ages.188
  Post-term pregnancies managed expectantly will also need extra operating expenses 
and resou ces in terms of follow-up examinations with CTG and ultrasound. Cost-
minimization analyses were conducted as part of the Canadian Multicenter Post-term 
Pregnancy Trial, and the mean costs per woman were found to be $ 3132 for a pregnancy 
managed expectantly and $ 2939 per patient who underwent induction of labour 
(p<0.0001).189
  
5  Basis for the study 
 
Obstetricians are always alert when a post-term woman is in labour at the delivery unit. The 
fact that there are different guidelines regarding post-term pregnancy management around the 
world, and a general feeling that there is no gold standard for medical treatment, we found it 
important to undertake new studies. 
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 In Scandinavia there has been a conservative approach to post-term pregnancy 
management.87, 98, 103, 104, 190 Most obstetricians in Norway follow the National Guidelines and 
await follow-up until 42 weeks. Swedish obstetricians have a similar approach. In a survey, 
87% of Swedish delivery units said that they would await spontaneous delivery in normal 
pregnancies until 42 weeks of gestation, and only 9% would induce labour at 41 weeks.42   
Antenatal surveillance was initiated at 41 weeks by 5% and at 42 weeks by 95% of the units.42 
The standard management of prolonged pregnancy in Finland has been antenatal surveillance 
from 41 to 42 weeks of gestation, and induction of labour at 42 weeks if the cervix is 
favourable.98
A meta-analysis on post-term pregnancy management has, however, recommended 
induction of labour after 41 weeks to reduce the risk of perinatal death. In the meta-analysis, 
routine induction of labour was not associated with an increased risk of caesarean section, 
regardless of parity, state of the cervix or method of induction, and there was no increase in 
instrumental delivery rate, use of analgesia or incidence of fetal heart rate abnormality.22  As a 
consequence, many countries changed their guidelines.112, 191   
However, this meta-analysis has created some discussion in the scientific 
community.103, 192 The major objections put forward have been that some fairly old studies 
were included, and that the Canadian Multicenter Post-term Pregnancy Trial strongly 
influenced the meta-analysis due to the sample size of the trial. This trial is not without 
criticism from obstetricians worldwide.87, 103, 192, 193   
The Canadian Multicenter Post-term Pregnancy Trial included 3407 women from 22 
hospitals. The aim of the trial was to determine the effect of routine induction of labour at 41 
weeks on perinatal mortality and neonatal morbidity as compared with a policy of expectant 
management with serial antenatal monitoring.30  A secondary objective of the trial was to 
determine if induction of labour resulted in increased or decreased rates of caesarean 
delivery.30 The study reported no differences in perinatal mortality or neonatal morbidity 
between the randomised groups, and induction of labour resulted in a decreased rate of 
caesarean delivery compared with serial antenatal monitoring (21.2% versus 24.5%, 
p=0.03).30 One important criticism towards the study was that different methods for 
estimating gestational age were used in the trial and that different methods for induction of 
labour were used in the randomised groups.87, 192  In the induction group cervix was ripened 
with prostaglandin gel, whereas labour was induced by oxytocin or amniotomy in the 
monitored group. The operative delivery rate was more than 50% in both trial arms, and it has 
been argued that the results might not be valid in West-European countries.87
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The guidelines from the Royal College of Obstetricians and Gynecologists (RCOG) 
conclude that ultrasound should be offered before 20 weeks gestation to confirm gestational 
age, and that women with uncomplicated pregnancies should be offered induction of labour 
after 41 weeks.112 The ACOG Practice Bulletin (American College of Obstetricians and 
Gynecologists) is less conclusive, and suggests that women with post-term pregnancies who 
have unfavourable cervices can either undergo labour induction or be managed expectantly.132 
A questionnaire was mailed to 1000 randomly selected ACOG Fellows and Junior Fellows to 
investigate attitudes and practice patterns toward post-term pregnancy. Post-term pregnancy is 
defined by ACOG as 42 weeks of gestation or more, but only 48% of the practicing 
obstetricians in the study defined post-term pregnancy as 42 weeks gestation or more.194 In 
all, 73% reported that they routinely induced low-risk patients with singletons at 41 weeks 
gestation.194
The meta-analysis on post-term pregnancy concluded that there was no need for 
further randomised trials of routine induction of labour versus conservative management.22  
However, a Swedish “State of the Art- management of post-term pregnancy” conference came 
to the opposite conclusion, recommending that a Scandinavian randomised trial should be 
done.87  A recently published study from Finland also concluded that there is an urgent need 
for a prospective randomised study on management of post-term pregnancies.98
 
 
6 Aims of the studies 
6.1 Study 1 
 
The aim of the study was to evaluate pregnancy complications and perinatal outcome for 
pregnancies at or beyond term when onset of labours were spontaneous or induced. 
6.2 Study 2 
 
The aim of the randomised controlled trial was to compare induction of labour at gestational 
age 289 days (41 weeks + 2 days) with expectant management with respect to neonatal 
morbidity. A secondary aim was to assess the effect of induction of labour and expectant 
management on the mode of delivery and maternal complications. 
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6.3 Study 3  
 
The aim of the survey was to explore women’s preferences of  post-term pregnancy 
management. We also wanted to study women’s experiences after participation in a clinical 
trial of routine antenatal fetal monitoring or induction of labour.  
6.4 Study 4 
 
The aim of this study was to assess risk estimates for fetal and perinatal deaths day by day 
beyond 41 completed weeks in a Norwegian population, and to estimate numbers needed to 
induce to avoid one fetal or perinatal death. 
 
7 Subjects and methods 
 
The study population in Study 1-3 came from a geographically well-defined area consisting of 
the city of Trondheim and eight surrounding municipalities. This area is served solely by St. 
Olavs Hospital, Trondheim University Hospital for all obstetric and perinatal care. In this 
non-selected population, 98 % of all pregnant women have a routine ultrasound scan at 
around 18 weeks and delivery at St. Olavs Hospital. 
7.1 Study 1 
 
Demographic characteristics, obstetrical history and data from all ultrasound scans were 
prospectively recorded in a computerized database. After delivery, additional data from the 
delivery and all neonatal outcomes were included in the database.  
Women were included if they had a singleton pregnancy with reliable dates and 
delivery beyond 37 weeks of gestation. The methods for induction of labour were 
amniotomy/oxytocin if cervix was favourable, and prostaglandin E2 when cervix was 
unfavourable. Post-term follow-up was initiated 14 days after the estimated date of delivery. 
If the pregnancy was uncomplicated, the woman attended follow-up examinations every 
second day until spontaneous delivery occurred or labour was induced at 43 completed weeks. 
7.2 Study 2 and 3 
 
Women were informed about the study when they attended the routine ultrasound scan at 
around 18 weeks. They were invited to book appointments at 41 weeks gestation. Eligible 
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women received a reminder phone call around 41 weeks if no follow-up appointment had 
been made.  
 All women had the same baseline assessment and answered the questionnaires on 
attitudes to post-term pregnancy at the time of inclusion. The methods used for induction of 
labour were amniotomy/oxytocin when cervix was favourable, and misoprostol when cervix 
was unfavourable (dinoprostone when the uterus was scarred). 
 Neonatal morbidity is a multifactorial outcome, and we chose to report commonly 
used and self-explanatory outcomes such as Apgar score, pH, Base excess, excessive birth 
weight, presence of infection or hypoglycaemia. In addition, we decided to report cut-off 
values for variables commonly considered to represent bad obstetric outcome (umbilical cord 
pH <7.10 or 7.00 or Base excess <12). A neonatal morbidity score (NEMO-score) was 
established for this study in order to compare groups quantitatively. NEMO score is a sum of 
deviations from the optimal neonatal outcome. We defined a perfect outcome as being an 
infant with a birth weight of 3.8 kg and a Ponderal Index of 2.88. Other optimal features for 
outcome were considered to be 1- and 5-minute Apgar scores of 10, umbilical cord pH 7.40 
with base excess equal to 0 (zero), and no medical complications or need for treatment. To 
compare the study groups quantitatively we assigned a priori weights to the outcome 
variables, based on clinical judgment and consensus among the researchers. The sum in each 
neonate constitutes a Neonatal Morbidity score, which increases with increasing morbidity. 
 A telephone survey 6-8 months post partum was performed by the principal author 
(78% of interviews) and one secretary (22% of interviews). The questionnaire on attitudes and 
preferences of management was established in cooperation with midwives, colleagues and 
patients, and the questionnaire was tested in a pilot study. 
7.3 Study 4 
 
The data source for this study was the Medical Birth Registry of Norway. The present analysis 
was based on an anonymous extraction file from all singleton births from 1999-2005. Births 
with gestational age < 287 days and > 315 days were excluded from the analyses, as were 
births with unknown gestational age. Fetal malformations were excluded from the study. 
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7.4 Statistics 
 
7.4.1 Statistical analyses 
 
In study 1, Pearson Chi-Square was used to test for differences in the crude analysis of 
perinatal outcomes and pregnancy complications. To assess linear associations across 
gestational weeks, we used the Chi-Square test for trend for proportions and linear regression 
for continuous variables. We performed a multivariable logistic regression analysis to control 
for possible confounders such as gender, smoking, maternal age, parity, and birth weight. The 
relative risks of complications were estimated and expressed as odds ratios (OR) with 95% 
confidence intervals (CI). 
 In study 2, groups were compared according to the intention to treat principle. 
Student’s t-test was employed for continuous variables. Mann-Whitney test was used for 
ordinal variables and Fisher’s exact tests with mid-p values for 2-by-2 tables.  
 In study 3, the Wilcoxon signed rank-test for paired observations was used to compare 
mean scores at inclusion and postpartum. Continuous variables are presented as means with 
standard deviations (SD), ordinal variables as medians with range, and categorical variables 
as numbers and percentages. Two-tailed tests were employed throughout the analyses, and a 
p-value < 0.05 was considered statistically significant. 
 In Study 4, differences in death rates and in numbers needed to treat were evaluated 
using proportion comparisons tests, and 95% CI for proportions were estimated using the 
exact option in the program package STATA. 
7.4.2 Sample size estimation 
 
Sample size estimation is not relevant in population based epidemiological studies (study 1 
and 4). 
 The randomised controlled trial had set a time frame of about two years, which made 
it realistic to enrol about 500 women. This sample size was considered acceptable in light of 
the results from two (unpublished) pilot studies, a retrospective study with n=20 and a 
prospective study with n=29. The pilot studies were undertaken prior to the trial to evaluate 
the feasibility of the NEMO score. Both pilot studies found a mean difference of about 1.5 
(with SD | 4) on the NEMO scale in favour of induction, and we found this difference to be 
clinically relevant. It corresponds to a standardized difference (mean difference /SD) of 0.38. 
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To detect a standardized difference of 0.3 with a power of 80% at a two-sided significance 
level of 5% we would need 176 subjects in each group. The final sample size of 254 in each 
group enabled a detection of a standardized difference of 0.25 (i.e. approximately 1.0 on the 
NEMO scale), and an absolute difference of 10% regarding operative deliveries.195  
 
8 Main results 
8.1 Study 1 
 
In this epidemiological study we found that poor pregnancy outcomes varied with gestational 
age and onset of labour. Both post-term pregnancy and induced labour were prognostic 
factors for poor obstetric and neonatal outcome. 
The caesarean delivery rate was stable around 12%, and the overall proportion of 
operative vaginal deliveries was constant around 8%. Maternal complications varied with 
gestational age, and were lowest at 39 weeks and highest post-term (caesarean delivery 12.3–
21.6%, operative vaginal delivery 10.7–15.4%, maternal haemorrhage 9.7–14.6%). Poor 
neonatal outcome varied with gestational age only for spontaneous labours (Apgar < 7 at 5 
minutes; 1.0–2.3%, pH < 7.10; 3.4 –5.2%). 
Induction of labour was a risk factor for delivery complications (OR 1.3–2.8), 
independent of gestational weeks, as were maternal age >35 years and nulliparity. 
8.2 Study 2 
 
In this randomised controlled trial we found no differences in neonatal morbidity or delivery 
complications between the groups. Neonatal outcome was generally good, and there were no 
differences in the proportions of NICU admissions, Apgar scores or umbilical blood pH. 
When all outcome measures in the scoring systems developed for post-term morbidity (the 
NEMO score and the score used in the Canadian Multicenter Post-term Pregnancy trial) were 
assessed, we found no differences between groups. However, there was a trend towards more 
frequently observed meconium-stained amniotic fluid during labour in the monitoring group 
(p=0.08), and the neonates were 0.4 cm longer (p<0.01) and tended to have higher birth 
weights (p=0.09). 
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 There was no difference in the caesarean delivery rate between the groups. Precipitate 
labours and short active second stage labours occurred more frequently in the induced group. 
In the monitoring group, an active second stage > 60 minutes was more frequently seen. 
8.3 Study 3 
 
At 41 weeks the majority of women (73%) preferred immediate induction, despite the fact 
that 40% of them believed that the complication rate would increase if labour was induced. 
After delivery, four of five women in the induction group said they would be keen to follow 
the same management pathway in a future pregnancy. Only two of five women who had serial 
antenatal monitoring would prefer this option again. In the monitored group the proportion of 
women who thought induction at 41 weeks should be mandatory was larger when they were 
asked 6-8 months after delivery. This change in attitude was not observed in the induction 
group. The majority of women (84%) reported a positive labour induction experience. 
8.4 Study 4 
 
The perinatal death rate increased with increasing gestational age (0.18‰ at day 288 to 5.1‰ 
at day 302+, p<0.001). NNTs (inductions necessary to avoid one IUFD or perinatal death) 
decreased with increasing gestational age (p<0.004). NNT for IUFD was 671 at day 287 and 
195 at day 302+. NNT for perinatal death was 527 at day 287 and 195 at day 302+. 
 
9 Discussion and interpretation of the results 
 
Study 1 was an observational study of the medical consequences of gestational age and 
induction of labour in a Norwegian population. We observed that both post-term pregnancy 
and induction of labour were independent risk factors for poor outcome. We acknowledged 
that only a randomised controlled trial could bring further information on this topic. 
 The most recent Norwegian randomised controlled trial on post-term pregnancy was 
published 20 years ago.196 The study was well designed and was included in a Cochrane 
review of 18 studies on post-term pregnancy management.83 Augensen et al. found no 
differences between the groups in the trial, and the authors concluded that either type of 
management (induction at 42 or 43 weeks) appeared to be safe. However, this trial was 
performed before prostaglandins were introduced for labour induction. This may explain the 
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high proportion of failed inductions (23%) in the trial. Furthermore, this trial was performed 
before ultrasound was generally available. A large proportion of women (57%) were excluded 
from the trial, mostly because of unreliable dates. Compared to today, the caesarean delivery 
rate was rather low (7-8%). However, the operative vaginal delivery rate was around 10%, 
and this is comparable to our trial. The results from the two Norwegian studies done 20 years 
apart were quite similar, but induction of labour was done a few days earlier in the most 
recent trial. It is noteworthy, however, that the clinical conclusions and recommendations 
from the two trials differ. Augensen et al. proposed that induction of labour should be 
postponed due to the minimal risk of expectant management. We argue for the opposite 
conclusion due to several reasons, but primarily due to the increasing perinatal mortality rate 
post-term. This was demonstrated in Study 1 and 4, and has also been found in many other 
studies. 22, 28, 75, 83 Further, the majority of women prefer induction of labour rather than 
antenatal fetal surveillance.  
For years obstetricians have been convinced that induction of labour cause maternal 
and neonatal complications. The results in Study 1 support this theory. In 1998 the Norwegian 
Medical Association carried out a “Break Through project on caesarean section” to try to 
reduce the increasing rate of caesarean deliveries. All labour units in Norway were invited to 
participate. Most participating units focused on a reduction in inductions as a possible way to 
reduce the caesarean delivery rate. Failed labour induction is a very negative experience for 
both mothers and obstetricians, and may be a contributing factor to their suggestion to 
postpone inductions. In Study 2 the rate of failed induction was rather low (6/293).  
A Cochrane review was available when Study 2 was planned. The review concluded 
that no further randomised controlled trials of routine induction of labour versus conservative 
management were needed.22 Thus, it may be argued that it was unnecessary, and perhaps even 
unethical, to go through with our trial. Lots of money and manpower are needed to conduct a 
randomised controlled trial, and patients have to spend time for examinations they otherwise 
would not have. On the other hand, Scandinavian management protocols of post-term 
pregnancy had not changed according to the conclusions from the Canadian Multicenter Post-
term Pregnancy trial or Cochrane, and there was a request for a new trial from Scandinavia.87 
The Scandinavian countries may be different from other countries for several reasons. The 
population is homogeneous, the operative delivery rates are low and the health care system is 
free of charge. Almost all women attend pregnancy care. 
 In Study 2 the pregnancy surveillance was done according to Scandinavian 
recommendations, and the operative delivery rates were comparable to rates from other 
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Scandinavian countries. Thus, the results of  the present trial may have an impact on 
Scandinavian practice. We anticipate that Scandinavian post-term pregnancy management  
protocols will become more in line with evidenced based medicine in the future.83, 112
 In the most recent Cochrane review from 2006, it is concluded that it would be useful 
to conduct research to obtain women’s views about management options.83 This was 
addressed in Study 3. At a post-term follow-up, a pregnant woman should be informed about 
a small but increased risk of stillbirth and perinatal death if she continues the pregnancy 
beyond 41 weeks. She should also be told that there is no difference in neonatal morbidity or 
caesarean delivery rate if she chooses expectant management or induction of labour. 
Expectant management is a legitimate option provided appropriate monitoring of pregnancy. 
Furthermore, she should be informed that most women report a positive experience with 
induction of labour, and that women who have been expectantly managed prefer induction of 
labour in a future pregnancy. However, the delivery may be somewhat more precipitate, and 
contractions may be more intense if labour is induced. This may be due to the misoprostol 
dosage regimen used in the most recent trial, and a lower dose of misoprostol may influence 
the women’s experience on this matter. 
 It is reasonable to believe that an even greater proportion of women would have a positive 
experience with induction of labour if the contractions were less intense. We have recently 
changed our dosage regimen for induction of labour at St. Olavs Hospital. The new low dose 
regimen is in line with the recommendations in the clinical guidelines from the Norwegian 
Society of Obstetrics and Gynecology,170 and these guidelines are in accordance with 
international recommendations.197 However, the use of low-dose regimens may be difficult 
and impracticable because the drug is currently only available in 100–200 ȝg tablets. The use 
of 25 ȝg requires multiple cutting of the tablet, involving a risk of inaccurate dosage. One 
previous study found that 42–74% of approximated one-quarter tablets (one-quarter of a 100-
microgram tablet) failed to provide misoprostol dose within 10% of the desired dose.198
  The methods for cervical ripening were different in Study 1 and Study 2. This may 
influence the comparison of the results, especially regarding outcomes of labour. In Study 1 
dinoprostone was used. This has been reported to be less effective compared with 
misopostol.153 In Study 2 the routine method for induction was misoprostol, and this was used 
in 239 women. In line with the study protocol, dinoprostone was used in 19 women with a 
scarred uterus. We believe that the larger proportion of prolonged first and second stages of 
labour found among induced labours in Study 1, but not in Study 2, may be related to the 
induction method.  
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There are reports of ruptured uterus after use of dinoprostone as well as 
misoprostol.179, 199 In a recent review article there were no differences in adverse maternal 
outcomes for misoprostol or prostaglandin E2 use.179 It has been stated that both elective 
caesarean section and induction of labour are reasonable choices for women with previous 
caesarean section.200 Others argue that women who undergo trial of labour after the estimated 
date of delivery have a significantly increased risk for scar rupture.201
The precautions taken towards induction of women with scarred uterus are mostly of 
medico legal character. Misoprostol is not approved for the induction of labour, and any 
misoprostol use among pregnant women must be considered to be “off-label” use of the drug. 
This “off-label” use has raised an important discussion between the manufacturer, 
governments and obstetricians worldwide.202-204 Misoprostol is cheap, thermostable (may be 
stored in room temperature), efficient and safe. However, the manufacturer does not want to 
apply for official use because they will not make much money, and they might face future 
litigations. Still, misoprostol is one of the most important medications in obstetrical practice. 
More than 200 studies involving more than 16 000 women have evaluated its effectiveness in 
pregnant women, and the results support its continued use.203  
As far as we know, there is only one previously published randomised controlled trial 
on post-term pregnancy management using misoprostol.205 The methods in the study by 
Gelisen et al. were somewhat different, and the results may be difficult to compare. The 
induction group in their study had three treatments arms: Vaginal administration of 50 μg 
misoprostol (n = 100), oxytocin induction (n =100) or transcervical insertion of a Foley 
catheter balloon (n = 100). Membrane sweeping were done in all groups before induction. In 
the study by Gelisen, induction of labour was scheduled in the monitored group at 294 days, 
in our study at 300 days. They reported that birth weight > 4000 g, shoulder dystocia, 
meconium-stained amniotic fluid, and meconium aspiration syndrome were significantly 
more frequently occurring in the follow-up group. Their findings on birth weight were in line 
with our results, but we could not demonstrate statistically significant differences in any other 
outcomes. 
 The proportion of self-reported smoking during pregnancy was different in Study 1 
and Study 2. In Study 1, 21% were smoking during pregnancy, but this proportion had 
dropped to 11-12% in study 2. Several factors may contribute to this difference. Pregnant 
women have quitted smoking quite dramatically in recent years. In 1987, Norway was on the 
top of the world list of smoking during pregnancy (35-40%) and in 1995 this proportion was 
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reduced to 20%.206 The proportion of smokers in our well defined population was 27% 
between 1987-1992.207  
 Smokers have reduced risk to deliver post-term.48 Study 1 included women from 37-
43 weeks of gestation, but the information about smoking habits was given when they 
attended routine ultrasound at around 18 weeks. In Study 2 they were asked about their 
smoking habits at 41 weeks. Some women may quit smoking during pregnancy.  
A limitation of our trial was that one third of the monitored women were induced 
because of medical indication. Induction for medical reasons was associated with increased 
intervention rates. The label of a “high-risk” pregnancy may have influenced the obstetrical 
decision making. The recognition of risk factors such as meconium-stained liquor resulted in 
the use of continuously electronic fetal monitoring rather than intermittent auscultation, and 
this may also have influenced intervention rates.208 We did not record the frequency of 
tachysystole or hyperstimulation, but we found no increase in nonreassuring fetal status in the 
induction group. 
It may be argued that stratification for parity should have been done in the trial, since 
nulliparous and parous women have different labour courses. We decided not to carry out a 
stratified allocation in the trial because we assumed that the process of randomisation would 
give a balanced distribution of nulliparous and parous women between study groups. Any 
subgroup analysis should be done with caution, and the trial was not powered to look at any 
subgroups. Thus, subgroup analyses were not done. 
The introduction of a new score (NEMO score) to measure neonatal morbidity is 
debatable. Neonatal morbidity is a multifaceted phenomenon, and we chose to report 
commonly used and self-explanatory outcomes such as Apgar score, pH, base excess, 
excessive birth weight, presence of infection, hypoglycaemia etc. because neonatal morbidity 
was the primary outcome of the study. In addition, we reported statistics on cut-off values for 
variables commonly considered to represent poor obstetric outcome (umbilical cord pH <7.10 
or 7.00 or base excess <12). However, we believe that a summarized score of morbidity is 
more clinical interesting than individual variables. This is also agreed by Caughey et al.92
 If a universally accepted morbidity score had been available, we would have used it 
in the trial. However, most published neonatal scoring systems focus on preterm neonates 
admitted to NICU and/or address neonatal mortality. In our trial neonates were post-term, 
only a small group of children were admitted to the NICU, and mortality was therefore not the 
focus of our study. Thus, we found previous scores unsuitable for our purpose.  
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 The proposed NEMO score is a sum of deviations from the optimal neonatal 
outcome. The weighting of the different variables may be debated, but they are transparent, 
and the scale itself may be interpreted from its components. Furthermore, the randomised 
design ensures that group comparison should be valid.  
 In addition we applied the score developed by Hannah et al. on our dataset.30 An 
adjudication of the definition in the CMPP- trial was made after the first 1500 infants were 
born, and a consensus conference was held to define further the measures of neonatal 
morbidity.30 This fact illustrates the complexity of the morbidity definition problem. In fact, 
Mary Hannah herself advised us not to use the CMPP-trial scoring system, and said “it was 
completely useless “(personal communication). We chose to report it anyway because we 
found it important to compare our results with the influential CMPP-trial. We do not know for 
sure that our score (NEMO score) is clinically more useful. Hannah et al. were unable to 
demonstrate any differences in morbidity with her scoring system in a study with 3400 
women. It was probably too optimistic to believe that we could demonstrate any statistically 
significant difference in a study with 500 women, although power calculations based on pilot 
studies indicated that this could be possible. On the other hand, if it is impossible to 
demonstrate any statistical difference in a randomised trial with 500 women, one might argue 
that there is hardly any difference of clinical importance between the groups. 
 Not all data from Study 2 and 3 have been analysed, and we aim to study one or more 
of the following topics: 
x Hormones in post-term pregnancy 
x Cervical changes in post-term pregnancy 
x Amniotic fluid measurements 
x IGFBP-1, cervical ripening and time to delivery 
x Smoking – second trimester, post-term and post partum 
  
10 Conclusions 
 
In Study 1 we found that both post-term pregnancy and induction of labour were prognostic 
factors for poor outcome. In Study 2 we found no differences between neonatal morbidity and 
mode of delivery for post-term pregnancies managed expectantly with serial antenatal 
surveillance or by immediate induction of labour. The outcomes were generally good. In 
Study 3 we found that the majority of women preferred induction of labour, and their 
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experiences with labour induction were good. There was a significant decrease in NNTs to 
avoid IUFD and perinatal death from 41 weeks to 43 weeks, but the NNTs were quite high. 
We suggest that induction of labour should be offered at 41 weeks of gestation. However, 
expectant management is a legitimate option provided appropriate monitoring of pregnancy.  
 
 
11 Final reflections and future aspects 
 
In the following section I will share my thoughts and vision for the future. Some thoughts are 
based on evidence, others are more speculative. 
There has been a shift in obstetric management during the last decade, and the 
proportion of induced labours is increasing worldwide. In a study from Minnesota, the 
increase in the induction rate for gestational age 37-41 was 130% between 1989 and 1998.169  
The gestational age distribution curve for induced births showed a marked shift to the left 
during the same period.169  The mean gestational age associated with inductions in post-term 
pregnancies decreased from an average of 41.9 weeks in 1980 to 41.0 weeks in 1995 
(p=0.001). In 1980 19% of all term deliveries were 42 weeks’ gestation and in 1995 this 
proportion had decreased to 2% (p=0.001).209  One of the largest overall increases in 
inductions was found to be in inductions labelled as elective.209 Caesarean on request and 
elective inductions both reflect the improved ability and wish to plan the timing of delivery. It 
has been proposed that women in the 21st  century will claim their rights to choose how, where 
and by whom they should be delivered.210 Modern women are used to plan their lives in 
detail, and schedule every hour of the day. Delivery is one of few unpredictable things in life. 
Many women find it unpleasant and fearful not to know when the labour starts, how painful it 
will be, how long it will last etc. One of the elements of uncertainty can be eliminated by 
induction of labour. Elective inductions will probably increase in the years to come.  
In Study 2 we demonstrated that the outcomes were generally good when labour was 
induced at 41 weeks, and in Study 3 we found that induction was preferred by most women. 
In Study 1 we demonstrated that the risk of complications generally was at the lowest at 
gestational week 38-39. If the trend to induce at earlier gestational ages continues, one future 
RCT should compare labour induction at 39 weeks and 41 weeks.  
Study 1 demonstrated that the complications at 39 weeks were low, but also that 
induction of labour was a risk factor for bad obstetric outcome. In a small randomised 
 48 
controlled trial from Japan (N=194),  labour was electively induced at 39 weeks or 
expectantly managed to 42 weeks.211 In this trial, there was an increased incidence of 
meconium stained amniotic fluid and need for fetal resuscitation in the expectant group, but 
no statistical significant differences in neonatal outcome or caesarean delivery rate.211  
A policy of early induction will implicate an enormous increase in the number of 
inductions, and medical consequences as well as logistic consequenses have to be considered. 
It is difficult to do cost-benefit analyses of induction of labours. According to a Canadian 
study, the cost of delivery after induction of labour was increased compared to spontaneous 
onset of labour.212 However, it is an interesting suggestion to be able to manage a great 
majority of deliveries. Perhaps a future obstetric department could be run mainly during 
daytime, where induction of labours and elective caesarean sections are scheduled. This might 
be cost saving, since human hospital resources could be used during daytime instead of week-
ends and nights. Obstetrics is the hallmark of emergency, and the activity and workload are 
the same 24 hours a day. A reduction of night-shifts among obstetricians and midwives may 
recruit young people to choose obstetrics. In our brand new department at St.Olavs Hospital, 
there are two identical delivery units. There are numerous delivery rooms, but there is a lack 
of staff and economy to operate two separate units 24 hours. A consequence analysis of a 
strategy of  two department open during day-time and one in the evening/nights would be 
interesting. It is of course impossible to schedule every single delivery, and flexible working 
shifts will be necessary. However, the induction to delivery time may to some extent be 
estimated from parity and cervical ripening, and one delivery unit could be run on a 8-5 basis.  
To follow this chain of thoughts further, one might imagine that the majority of 
women can have their labour induced on an out-patient basis. This may be a reasonable option 
for several reasons. One study demonstrated that a latency of approximately 15 hours after a 
single low dose of misoprostol can provide induction benefit and may minimize the problem 
of uterine tachysystole/hyperstimulation associated with repeated dosing.213  A single dose of 
misoprostol was more effective than a single dose of prostaglandin gel for out-patient labour 
induction.213 No differences in adverse outcomes were found between inpatient or outpatient 
induction of labour.214 However, the women in the outpatient group reported significantly 
more satisfaction than the inpatient women.214 In addition, the need of hospital resources will 
probably be reduced by an out-patient induction policy. 
Risk assessment has become popular in modern medicine. To help women to decide 
whether to have their labour induced or not, individual risk assessments based on likelihood-
ratios would be helpful. A computer programme using individual information about parity, 
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cervical status, amount of amniotic fluid, gestational age and maternal age etc. could give 
individual risks of spontaneous delivery within a few days, caesarean delivery or poor 
obstetric outcome. 
 
12 Corrections  
 
Paper I: 
 
Table 3- second column: Birth weight more than 4500 g 
 
Table 4- * deleted behind P value difference over gestational weeks 
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